or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    BPTH F Bio-Path Holdings Inc 1.43
    MTEM F Molecular Templates, Inc. -2.06
    ALXO F ALX Oncology Holdings Inc. 6.61
    TSBX F Turnstone Biologics Corp. 2.09
    APTO F Aptose Biosciences, Inc. -10.66
    ONCT F Oncternal Therapeutics, Inc. 1.75
    HOWL F Werewolf Therapeutics, Inc. 8.54
    CARM F Carisma Therapeutics, Inc. -1.69
    LYEL F Lyell Immunopharma, Inc. -11.01
    SNTI F Senti Biosciences, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Cancer Biotechnology Biopharmaceutical Acute Myeloid Leukemia Cancer Immunotherapy Life Sciences Lymphoma Medicine Oncology Treatment Of Cancer Biology Breast Cancer Cell Biology Cell Therapy Chimeric Antigen Receptor T Cell Clinical Medicine Hematologic Malignancies Immune System Immunotherapy Induced Stem Cells

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    GNOM F Global X Genomics & Biotechnology ETF 4.73
    IDNA D iShares Genomics Immunology and Healthcare ETF 4.42
    CNCR F Loncar Cancer Immunotherapy ETF 3.2
    SBIO C ALPS Medical Breakthroughs ETF 3.19
    WDNA D WisdomTree BioRevolution Fund 2.33
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare CNCR to SBIO Compare GNOM to IDNA Compare SBIO to WDNA

        Solid Tumors Stocks Recent News

        Date Stock Title
        Nov 21 ALXO ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
        Nov 20 HOWL Werewolf Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Healthcare Conference
        Nov 20 APTO Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy
        Nov 17 CARM Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024
        Nov 15 BPTH Bio-Path Holdings, Inc. (BPTH) Q3 2024 Earnings Call Transcript
        Nov 15 SNTI Senti Biosciences GAAP EPS of -$6.31
        Nov 15 BPTH Bio-Path: Q3 Earnings Snapshot
        Nov 15 BPTH Bio-Path GAAP EPS of -$0.70
        Nov 15 BPTH Bio-Path Holdings Reports Third Quarter 2024 Financial Results
        Nov 15 BPTH Earnings Scheduled For November 15, 2024
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Biopharmaceutical Cancer Immunotherapy Cancer Treatment Cell Biology Cell Therapy Leukemia Lymphoma Multiple Myeloma Acute Myeloid Leukemia Advanced Solid Tumors Antineoplastic Drugs Apoptosis Drugs Organ Systems Ovarian Cancer Pharmaceutical
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags